SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4rnr'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.06A 1zzrA-4rnrB:
undetectable
1zzrB-4rnrB:
undetectable
1zzrA-4rnrB:
19.49
1zzrB-4rnrB:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.08A 1zzrA-4rnrB:
undetectable
1zzrB-4rnrB:
undetectable
1zzrA-4rnrB:
19.49
1zzrB-4rnrB:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.05A 1zzuA-4rnrB:
undetectable
1zzuB-4rnrB:
undetectable
1zzuA-4rnrB:
19.49
1zzuB-4rnrB:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.06A 1zzuA-4rnrB:
undetectable
1zzuB-4rnrB:
undetectable
1zzuA-4rnrB:
19.49
1zzuB-4rnrB:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2KOT_A_ANWA99_0
(PROTEIN S100-A13)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B  75
THR B  74
PHE B  62
ARG B  54
None
1.27A 2kotA-4rnrB:
undetectable
2kotA-4rnrB:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y03_A_5FWA601_1
(BETA-1 ADRENERGIC
RECEPTOR)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
5 / 12 VAL A 163
VAL A 182
SER A 180
ASN A 197
ASN A 155
None
1.43A 2y03A-4rnrA:
undetectable
2y03A-4rnrA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y03_B_5FWB601_1
(BETA-1 ADRENERGIC
RECEPTOR)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
5 / 12 VAL A 163
VAL A 182
SER A 180
ASN A 197
ASN A 155
None
1.46A 2y03B-4rnrA:
undetectable
2y03B-4rnrA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.10A 3dqrA-4rnrB:
undetectable
3dqrB-4rnrB:
undetectable
3dqrA-4rnrB:
19.39
3dqrB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.14A 3dqrA-4rnrB:
undetectable
3dqrB-4rnrB:
undetectable
3dqrA-4rnrB:
19.39
3dqrB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_A_PNNA302_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
4 / 6 LEU A 189
GLY A 190
ALA A 125
PRO A 126
None
0.50A 3huoA-4rnrA:
undetectable
3huoA-4rnrA:
23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.04A 3jx2A-4rnrB:
undetectable
3jx2B-4rnrB:
undetectable
3jx2A-4rnrB:
19.39
3jx2B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.06A 3jx2A-4rnrB:
undetectable
3jx2B-4rnrB:
undetectable
3jx2A-4rnrB:
19.39
3jx2B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.07A 3jx3A-4rnrB:
undetectable
3jx3B-4rnrB:
undetectable
3jx3A-4rnrB:
19.39
3jx3B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.07A 3jx3A-4rnrB:
undetectable
3jx3B-4rnrB:
undetectable
3jx3A-4rnrB:
19.39
3jx3B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.11A 3jx4A-4rnrB:
undetectable
3jx4B-4rnrB:
undetectable
3jx4A-4rnrB:
19.39
3jx4B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.06A 3jx5A-4rnrB:
undetectable
3jx5B-4rnrB:
undetectable
3jx5A-4rnrB:
19.39
3jx5B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.09A 3jx5A-4rnrB:
undetectable
3jx5B-4rnrB:
undetectable
3jx5A-4rnrB:
19.39
3jx5B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
0.99A 3jx6A-4rnrB:
undetectable
3jx6B-4rnrB:
undetectable
3jx6A-4rnrB:
19.39
3jx6B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.04A 3jx6A-4rnrB:
undetectable
3jx6B-4rnrB:
undetectable
3jx6A-4rnrB:
19.39
3jx6B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NBR_A_ASDA129_1
(STEROID
DELTA-ISOMERASE)
4rnr PGT130 HEAVY CHAIN
PGT130 LIGHT CHAIN

(Homo
sapiens)
5 / 12 PHE A 166
VAL B 195
VAL B 144
PRO B 113
PHE B 139
None
1.41A 3nbrA-4rnrA:
undetectable
3nbrA-4rnrA:
17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.00A 3nljA-4rnrB:
undetectable
3nljB-4rnrB:
undetectable
3nljA-4rnrB:
19.39
3nljB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.06A 3nljA-4rnrB:
undetectable
3nljB-4rnrB:
undetectable
3nljA-4rnrB:
19.39
3nljB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.04A 3nlpA-4rnrB:
undetectable
3nlpB-4rnrB:
undetectable
3nlpA-4rnrB:
19.39
3nlpB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.09A 3nlpA-4rnrB:
undetectable
3nlpB-4rnrB:
undetectable
3nlpA-4rnrB:
19.39
3nlpB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 8 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
0.99A 3nlqA-4rnrB:
undetectable
3nlqB-4rnrB:
undetectable
3nlqA-4rnrB:
19.39
3nlqB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.06A 3nlqA-4rnrB:
undetectable
3nlqB-4rnrB:
undetectable
3nlqA-4rnrB:
19.39
3nlqB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.04A 3nlrA-4rnrB:
undetectable
3nlrB-4rnrB:
undetectable
3nlrA-4rnrB:
19.39
3nlrB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 8 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.06A 3nlrA-4rnrB:
undetectable
3nlrB-4rnrB:
undetectable
3nlrA-4rnrB:
19.39
3nlrB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NYA_A_JTZA1203_1
(BETA-2 ADRENERGIC
RECEPTOR, LYSOZYME)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
5 / 12 VAL A 163
VAL A 182
SER A 180
ASN A 197
ASN A 155
None
1.43A 3nyaA-4rnrA:
undetectable
3nyaA-4rnrA:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.07A 4cx3A-4rnrB:
undetectable
4cx3B-4rnrB:
undetectable
4cx3A-4rnrB:
19.39
4cx3B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.07A 4cx3A-4rnrB:
undetectable
4cx3B-4rnrB:
undetectable
4cx3A-4rnrB:
19.39
4cx3B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.08A 4cx4A-4rnrB:
undetectable
4cx4B-4rnrB:
undetectable
4cx4A-4rnrB:
19.39
4cx4B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.08A 4cx4A-4rnrB:
undetectable
4cx4B-4rnrB:
undetectable
4cx4A-4rnrB:
19.39
4cx4B-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_A_NCTA501_1
(CYTOCHROME P450 2A6)
4rnr PGT130 HEAVY CHAIN
PGT130 LIGHT CHAIN

(Homo
sapiens)
4 / 7 PHE B  98
PHE A 100
ASN A  60
GLY A  49
None
0.90A 4ejjA-4rnrB:
undetectable
4ejjA-4rnrB:
19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_B_NCTB501_1
(CYTOCHROME P450 2A6)
4rnr PGT130 HEAVY CHAIN
PGT130 LIGHT CHAIN

(Homo
sapiens)
4 / 7 PHE B  98
PHE A 100
ASN A  60
GLY A  49
None
1.02A 4ejjB-4rnrB:
undetectable
4ejjB-4rnrB:
19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LDO_A_ALEA1402_1
(LYSOZYME, BETA-2
ADRENERGIC RECEPTOR)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
5 / 10 VAL A 163
VAL A 182
SER A 180
ASN A 197
ASN A 155
None
1.45A 4ldoA-4rnrA:
undetectable
4ldoA-4rnrA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RFQ_A_SAMA401_1
(HISTIDINE PROTEIN
METHYLTRANSFERASE 1
HOMOLOG)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 4 THR B  26
GLY B  93
ASP B  95
SER B  27
None
1.37A 4rfqA-4rnrB:
undetectable
4rfqA-4rnrB:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADD_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.02A 5addA-4rnrB:
undetectable
5addB-4rnrB:
undetectable
5addA-4rnrB:
19.39
5addB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADE_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.04A 5adeA-4rnrB:
undetectable
5adeB-4rnrB:
undetectable
5adeA-4rnrB:
19.39
5adeB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 VAL B 106
ARG B  61
VAL B  19
GLU B  83
None
1.07A 5g0pA-4rnrB:
undetectable
5g0pB-4rnrB:
undetectable
5g0pA-4rnrB:
19.39
5g0pB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 7 GLU B  83
VAL B 106
ARG B  61
VAL B  19
None
1.10A 5g0pA-4rnrB:
undetectable
5g0pB-4rnrB:
undetectable
5g0pA-4rnrB:
19.39
5g0pB-4rnrB:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4I_A_6J3A201_0
(TRANSTHYRETIN)
4rnr PGT130 LIGHT CHAIN
(Homo
sapiens)
4 / 6 LEU B 132
ALA B 130
LEU B 178
THR B 181
None
1.02A 5l4iA-4rnrB:
undetectable
5l4iA-4rnrB:
23.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DRZ_A_H8JA1206_0
(5HT2B RECEPTOR, BRIL
CHIMERA)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
5 / 12 VAL A 207
THR A 205
VAL A 211
GLY A 118
VAL A 152
None
1.00A 6drzA-4rnrA:
undetectable
6drzA-4rnrA:
17.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H7M_B_68HB405_0
(BETA-1 ADRENERGIC
RECEPTOR)
4rnr PGT130 HEAVY CHAIN
(Homo
sapiens)
5 / 12 VAL A 163
VAL A 182
SER A 180
ASN A 197
ASN A 155
None
1.41A 6h7mB-4rnrA:
undetectable
6h7mB-4rnrA:
14.93